🇺🇸 FDA
Pipeline program

Anti-Arrhythmics

STUDY00003861

Approved small_molecule terminated

Quick answer

Anti-Arrhythmics for Arrhythmia, Cardiac is a Approved program (small_molecule) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Rhythm Pharmaceuticals Netherlands B.V.
Indication
Arrhythmia, Cardiac
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials